SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Dexcom Inc., one of San Diego’s biggest public medical technology firms, announced May 2 that it will acquire Nintamed, a distribution partner with presence in Germany, Switzerland and Austria.
Local philanthropists Gary and Mary West have provided $11.8 million to the University of California, San Diego to create a senior emergency care unit at the future Jacobs Medical Center.
MedOptions announced a definitive agreement to acquire San Diego’s Vericare, a behavioral health clinical care provider.
San Diego’s MyDx Inc., a company that makes a handheld chemical analyzer for consumers, announced a jump in quarterly revenue as the startup gains traction.
San Diego-based Biocept Inc. is hoping to raise $5 million in an offering of its common stock, the company announced April 29.
San Diego’s Ignyta Inc., a drugmaker developing cancer therapeutics, is hoping to raise $50 million in an offering of its common stock, the company announced Wednesday.
Dexcom Inc., one of San Diego’s biggest public medical technology firms, reported a 60 percent jump in revenue for the first quarter of this year.
San Diego medical device company ResMed Inc. reported a drop in net income for the first quarter of 2016.
San Diego medical device maker NuVasive Inc. exceeded Wall Street expectations Tuesday when it reported a boost in revenue and an improved bottom line.
Millennium Health, a drug-testing firm in San Diego, announced that Chairman of the Board Ronald Rittenmeyer is taking over as CEO.
A month after abruptly firing two top executives, San Diego’s cancer test company Trovagene Inc. has appointed a new CEO.
BIOTECH: Co. Emerges With Anti-Aging Results; Some in Industry Are Skeptical
Osman Kibar is nonchalant, as billionaires go, but he’s nothing if not confident. Dressed in a fading polo shirt and old jeans, he leans back in his chair, intertwines his fingers and fights a knowing smile. He knows why I’m here.
San Diego’s Human Longevity Inc. struck a deal with pharma giant AstraZeneca and its global biologics R&D arm, MedImmune, the companies announced April 21.
San Diego medtech Skylit Medical raised fresh capital this week and added two board members.